Healthcare -
Biotechnology - NASDAQ - US
$ 50.35
0.76 %
$ 5.94 B
Market Cap
-9.36
P/E
CYTK - COST OF REVENUE
Cost of Revenue CYTK - Cytokinetics, Incorporated
330 M
LAST VALUE
43.67%
2 YEAR CAGR
29.93%
5 YEAR CAGR
20.91%
10 YEAR CAGR